Full Breakdown
Johnson & Johnson's Talc Products Face Legal Challenges Over Cancer Claims
1/21/2026, 6:54:47 AM
Overview of the Legal Proceedings
A federal judge's recent ruling has allowed expert testimony linking Johnson & Johnson's (J&J) talc products to ovarian cancer in a significant legal battle involving over 67,500 lawsuits consolidated in federal court in New Jersey. The decision, made by U.S. District Judge Michael Shipp, permits plaintiffs to present scientific evidence that may establish a causal relationship between the use of J&J's baby powder and ovarian cancer, potentially paving the way for the first trial later this year.
Background of the Litigation
The litigation against J&J stems from claims that its talc-based products, including baby powder, have caused ovarian cancer in numerous women. The company ceased the sale of talc-based baby powder in the U.S. in 2020, transitioning to a cornstarch-based alternative. The legal proceedings have been ongoing since 2016, with retired U.S. District Judge Freda Wolfson previously overseeing the multidistrict litigation. In 2020, she allowed expert testimony regarding the potential link between talc and cancer due to contamination with asbestos and heavy metals, a claim J&J has consistently denied.
Key Developments in the Case
The recent ruling by Judge Shipp comes after a reevaluation of scientific evidence, influenced by new federal rules governing expert testimony and emerging research. J&J has attempted to resolve the litigation through bankruptcy, a strategy that has been rejected multiple times by federal courts. The company has faced mixed outcomes in state courts, with some trials resulting in substantial verdicts, including a notable $4.69 billion award to 22 women in one case.
Criticism and Opposition
In its defense, J&J has taken legal action against scientists whose research supports the plaintiffs, alleging that these experts falsified results by including individuals likely exposed to asbestos through other means. While some lawsuits against these scientists remain pending, others have been dismissed. Critics argue that J&J's tactics reflect an aggressive strategy to undermine scientific evidence and delay justice for affected individuals.
Recent Verdicts and Settlements
In addition to ovarian cancer claims, J&J has faced lawsuits alleging its talc products caused mesothelioma, a rare and deadly cancer. The company has settled some of these claims but has not reached a nationwide settlement, leading to ongoing trials in state courts. Recently, J&J has encountered significant verdicts in mesothelioma cases, including a $1.5 billion judgment in Baltimore in December 2025.
Official Statements & Responses
J&J maintains that its talc products are safe and do not cause cancer. The company has expressed its commitment to defending its products in court and has consistently challenged the scientific basis of the claims against it.
What's Next
As the litigation progresses, the upcoming trials will be critical in determining the outcomes for the thousands of women involved in the lawsuits. The court's acceptance of expert testimony may significantly influence the direction of the cases and the potential for future settlements or verdicts.
